[FURL=https://www.industryarc.com/Report/19474/us-clinical-laboratory-tests-market.html?utm_source=briefingwire&utm_medium=pressrelease&utm_campaign=paidpressrelease]U.S. Clinical Laboratory Tests Market[/FURL] size is forecast to reach $94.7 billion by 2026, growing at a CAGR of 8.1% during the forecast period 2021-2026. A collective number of medical tests which are ought to be performed in a laboratory containing all equipment and medicines ideally for disease diagnosis and treatment are called clinical laboratory tests. The tests have an exhaustive variety like Complete Blood Count (CBC), Basic Metabolic Panel (BMP), Erythrocyte Sedimentation Rate(ESR) and BUN Creatinine testing, to name a few.Key Takeaways
The Clinical Laboratory Tests Market is prominent in the U.S. owing to rising penetration of advanced diagnostic techniques and increasing test volumes support.
Growing prevalence of chronic diseases due to unhealthy lifestyle coupled with a number of geriatric population throughout the U.S. are likely to aid the market growth of the U.S. Clinical Laboratory Tests Market report.
Detailed analysis of the Strength, Weakness, and Opportunities of the prominent players operating in the market will be the U.S. Clinical Laboratory Tests Market report.
Lack of skilled labor throughout the country is poised to create hurdles for the U.S. Clinical Laboratory Tests Market.
Download Sample Report @ [FURL]www.industryarc.com/pdfdownload.php?id=19474[/FURL]
U.S. Clinical Laboratory Tests Market Segment Analysis – By End User
The central laboratories segment held the largest share in the U.S. Clinical Laboratory Tests Market in 2020 and is estimated to grow at a CAGR of 7.7% during the forecast period 2021-2026. This is owing to the growing number of central laboratories where most of the variety of tests can be conducted under one roof. Some of such laboratories like Phoenix Lab, Q2 Solutions, Pharmaceutical Product Development, LLC, CIRION BioPharma Research Inc., Covance Inc., and Eurofins Scientific has grown considerably over time. However, primary clinics are also gaining traction because of the growing demand for rapid-speed test results, especially in the advent of a covid-19 pandemic.
U.S. Clinical Laboratory Tests Market Drivers
Growing prevalence of chronic diseases due to unhealthy lifestyles is driving the market growth
Growing geriatric population throughout the U.S. suffering from hearing loss and cataracts is poised to increase the growth of the market
U.S. Clinical Laboratory Tests Market Landscape
The U.S. Clinical Laboratory Tests Market, top 10 companies are Abbott, OPKO Health, Inc., NeoGenomics Laboratories, Inc., Laboratory Corporation of America Holdings (LabCorp), Fresenius Medical Care, Quest Diagnostics, Siemens Healthcare Private Limited, Sonic Healthcare, Merck KgaA, Biosino Biotechnology and Science Inc.
About IndustryARC: IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to sales@industryarc.com to discuss more about our consulting services.